Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $25.2B | $24.3B | $26.3B | $37.8B | $52.6B | $41.9B | $45.7B | $58.7B | $61.0B | $61.3B | $57.8B | $43.5B | $42.9B | $45.8B | $45.7B | $41.1B | $41.4B | $59.2B | $67.2B | $59.5B |
Discover the top 20 best undervalued stocks to buy for Nov 2024, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Nov 2024, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Nov 2024.
As of today, Bunge Limited's last 12-month Revenue is $54.5B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Bunge Limited's Revenue growth was (11.0%). The average annual Revenue growth rates for Bunge Limited have been 6.4% over the past three years, 5.4% over the past five years.
Over the last year, Bunge Limited's Revenue growth was (11.0%), which is lower than industry growth of (0.2%). It indicates that Bunge Limited's Revenue growth is Bad.